Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin vs glibenclamide add-on to metformin in type 2 diabetes
2009-014727-23Phase 4Terminated
- Sponsor
- Prof. Ivana Zavaroni
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Metformin + vildagliptin with Metformin + glibenclamide (2 arms). Primary endpoint: Primary composite glycemic failure rate. Started Oct 2009; status: terminated.
02
Drugs
vildagliptinglibenclamidemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-014727-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014727-23.